Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Osmetech tests e-nose in bacterial vaginosis trial:

This article was originally published in Clinica

Executive Summary

UK firm Osmetech has commenced clinical trials for its "electronic nose" sensor for use in detecting bacterial vaginosis. Data obtained from the clinical trials, which will take place in both UK and US hospitals, will be used to support a US FDA marketing application, which the company expects to file by the end of April 2002. In a pre-trial study at John Hopkins Hospital, Baltimore, the bacterial vaginosis sensor gave more objective and significantly faster diagnostic readings than current testing methods, said the Crewe-based firm. The device, which detects gases emitted by bacterial metabolism, last month gained FDA approval for detection of urinary tract infections (see Clinica No 986, p 19).





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts